We reported previously that
NSC606985, a
camptothecin analogue, induces apoptosis of
acute myeloid leukemia (AML) cells through proteolytic activation of
protein kinase C delta (DeltaPKC-delta). By subcellular
proteome analysis,
heterogeneous nuclear ribonucleoprotein K (
hnRNP K) was identified as being significantly down-regulated in NSC606985-treated leukemic NB4 cells.
HnRNP K, a docking
protein for
DNA,
RNA, and transcriptional or translational molecules, is implicated in a host of processes involving the regulation of gene expression. However, the molecular mechanisms of
hnRNP K reduction and its roles during apoptosis are still not understood. In the present study, we found that, following the appearance of the DeltaPKC-delta,
hnRNP K protein was significantly down-regulated in
NSC606985,
doxorubicin,
arsenic trioxide and ultraviolet-induced apoptosis. We further provided evidence that DeltaPKC-delta mediated the down-regulation of
hnRNP K protein during apoptosis: PKC-delta inhibitor could rescue the reduction of
hnRNP K;
hnRNP K failed to be decreased in PKC-delta-deficient apoptotic KG1a cells; conditional induction of DeltaPKC-delta in U937T cells directly down-regulated
hnRNP K protein. Moreover, the
proteasome inhibitor also inhibited the down-regulation of
hnRNP K protein by apoptosis inducer and the conditional expression of DeltaPKC-delta. More intriguingly, the suppression of
hnRNP K with
siRNA transfection significantly induced apoptosis. To our knowledge, this is the first demonstration that proteolytically activated PKC-delta down-regulates
hnRNP K protein in a
proteasome-dependent manner, which plays an important role in apoptosis induction.